Target intelligence / Profile preview

Skin and skin microbiome ecosystem

Molecular classification
Other
01

Overview

The skin and skin microbiome ecosystem is a complex biological environment comprising human skin cells and a diverse array of microorganisms, including bacteria, fungi, viruses, and mites (Byrd et al., 2018, Nature Reviews Microbiology). This ecosystem functions as a critical physical and immunological barrier, where commensal microbes compete with pathogens for nutrients and produce antimicrobial substances to prevent colonization by harmful species (Grice & Segre, 2011, Nature Reviews Microbiology). It also plays a vital role in educating the host immune system and maintaining skin homeostasis (Belkaid & Segre, 2014, Science). Disruptions to this delicate balance, termed dysbiosis, are associated with various dermatological disorders, including atopic dermatitis, acne vulgaris, and psoriasis (Kong et al., 2012, Genome Research). Therapeutic interventions targeting this ecosystem range from traditional antibiotics and antifungals to emerging approaches like probiotics, prebiotics, and microbiome transplants designed to restore microbial diversity and function (Wallen-Russell, 2019, Cosmetics). Understanding the symbiotic relationship between the host and its microbiota is essential for developing precision treatments for skin diseases.

Other names
Skin microbiotaSkin floraCutaneous microbiomeDermal microbiome
02

Mechanism of action

Modulation of the microbial community structure and host-microbe interactions to restore skin homeostasis and barrier function (Byrd et al., 2018, Nature Reviews Microbiology).

03

Biological functions

Immune responseBarrier functionPathogen defenseMetabolic regulationWound healing
04

Disease associations

InfectionInflammationAtopic dermatitisAcne vulgarisPsoriasisRosaceaSeborrheic dermatitis
05

Safety considerations

Development of antimicrobial resistance (NIH)Induction of skin irritation or contact dermatitisRisk of systemic infection in immunocompromised individualsUnintended disruption of the commensal flora (dysbiosis)
06

Interacting drugs

Benzoyl peroxide

7 more in the full profile.

07

Biomarkers

Staphylococcus aureus abundance (Byrd et al., 2017)Shannon diversity index (Kong et al., 2012)Skin surface pH (Grice & Segre, 2011)Cutibacterium acnes phylotype diversity (Fitz-Gibbon et al., 2013)

Beyond the preview

Go deeper on Skin and skin microbiome ecosystem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin and skin microbiome ecosystem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call